Baculovirus as an Ideal Radionuclide Reporter Gene Vector: A New Strategy for Monitoring the Fate of Human Stem Cells In Vivo

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Pan, Yu ^a   Liu, Shuai ^a   Wu, Haifei ^a   Lv, Jing ^a   Xu, Xiaoqian ^b   Zhang, Yifan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACULOVIRUS VECTOR; CHOLECYSTOKININ OCTAPEPTIDE; GREEN FLUORESCENT PROTEIN; IODINE 125; PERCHLORATE; SODIUM IODIDE SYMPORTER;

ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CELL FATE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EMBRYONIC STEM CELL; FEASIBILITY STUDY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GREEN FLUORESCENT PROTEIN GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MESENCHYMAL STEM CELL; MOUSE; NANOIMAGING; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REPORTER GENE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SODIUM IODIDE SYMPORTER GENE; STEM CELL TRANSPLANTATION;

ANIMALS; BACULOVIRIDAE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRACKING; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MESENCHYMAL STROMAL CELLS; MICE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOISOTOPES; STEM CELL TRANSPLANTATION; STEM CELLS; SYMPORTERS; TRANSDUCTION, GENETIC;

MUS;

EID: 84876186812     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061305     Document Type: Article

References (59)

1. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918 DOI:10.1161/01.cir.0000034046.87607.1c.
2. Fassas A, Kimiskidis VK, Sakellari I, Kapinas K, Anagnostopoulos A, et al. (2011) Long-term results of stem cell transplantation for MS A single-center experience. Neurology 76: 1066-1070 DOI:10.1212/WNL.0b013e318211.
3. Morizane A, Darsalia V, Guloglu MO, Hjalt T, Carta M, et al. (2010) A simple method for large-scale generation of dopamine neurons from human embryonic stem cells. J Neurosci Res 88: 3467-3478 DOI:10.1002/jnr.22515.
4. Voltarelli JC, Couri CEB, Stracieri ABPL, Oliveira MC, Moraes DA, et al. (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA-J Am Med Assoc 297: 1568-1576 DOI:10.1001/jama.297.14.1568.
5. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, et al. (2006) Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24: 1392-1401 DOI:10.1038/nbt1259.
6. van der Bogt KEA, Swijnenburg RJ, Cao F, Wu JC, (2006) Molecular imaging of human embryonic stem cells- Keeping an eye on differentiation, tumorigenicity and immunogenicity. Cell Cycle 5: 2748-2752 DOI:10.4161/cc.5.23.3533.
7. Hayflick L, (1961) The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res 23: 14-20 DOI:10.1016/0014-4827(61)90059-3.
8. Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, et al. (2008) In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev 17: 1023-1029 DOI:10.1089/scd.2008.0091.
9. Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, et al. (2008) Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A 105: 12991-12996 DOI:10.1073/pnas.0805802105.
10. Cao F, van der Bogt KEA, Sadrzadeh A, Xie X, Sheikh AY, et al. (2007) Spatial and temporal kinetics, of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 16: 883-891 DOI:10.1089/scd.2007.0160.
11. Lee AS, Tang C, Cao F, Xie X, van der Bogt K, et al. (2009) Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8: 2608-2612 DOI:10.4161/cc.8.16.9353.
12. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872 DOI:10.1016/j.cell.2007.11.019.
13. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920 DOI:10.1126/science.1151526.
14. Sun N, Longaker MT, Wu JC, (2010) Human iPS cell-based therapy Considerations before clinical applications. Cell Cycle 9: 880-885 DOI:10.4161/cc.9.5.10827.
15. Pournasr B, Khaloughi K, Salekdeh GH, Totonchi M, Shahbazi E, et al. (2011) Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells. Stem Cells 29: 1933-1941 DOI:10.1002/stem.760.
16. Okita K, Yamanaka S, (2011) Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc B-Biol Sci 366: 2198-2207 DOI:10.1098/rstb.2011.0016.
17. Yang SE, Ha CW, Jung MH, Jin HJ, Lee MK, et al. (2004) Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 6: 476-486 DOI:10.1080/14653240410005041.
18. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301 DOI:10.1634/stemcells.2005-0342.
19. Barry FP, Murphy JM, (2004) Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36: 568-584 DOI:10.1016/j.biocel.2003.11.001.
20. Watt SM, Contreras M, (2005) Stem cell medicine: Umbilical cord blood and its stem cell potential. Semin Fetal Neonatal Med 10: 209-220 DOI:10.1016/j.siny.2005.02.001.
21. Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, et al. (2012) Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax. In press. DOI: 10.1136/thoraxjnl-2012-202323.
22. Zhang X, Zhang L, Xu W, Qian H, Ye S, et al. (2013) Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery. Curr Cancer Drug Targets 13: 92-102 DOI:http://dx.doi.org/10.2174/156800913804486665.
23. Jin JL, Liu Z, Lu ZJ, Guan DN, Wang C, et al. (2013) Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res 10: 11-20 DOI:http://dx.doi.org/10.2174/156720213804805936.
24. Liu R, Zhang Z, Lu Z, Borlongan CV, Pan J, et al. (2012) Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. Stem Cells Dev. In press. DOI: 10.1089/scd.2012.0463.
25. Yan C, Li S, Li Z, Peng H, Yuan X, et al. (2013) Human umbilical cord mesenchymal stem cells as vehicles of cd20-specific trail fusion protein delivery: a double-target therapy against non-hodgkin's lymphoma. Mol Pharm 10: 142-151 DOI:10.1021/mp300261e.
26. Dove A, (2002) Cell-based therapies go live. Nat Biotechnol 20: 339-343 DOI:10.1038/nbt0402-339.
27. Sykova E, Jendelova P, (2007) Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 14: 1336-1342 DOI:10.1038/sj.cdd.4402140.
28. Wu JC, Abraham MR, Kraitchman DL, (2010) Current perspectives on imaging cardiac stem cell therapy. J Nucl Med 51Suppl 1: 128S-136S DOI:10.2967/jnumed.109.068239.
29. Higuchi T, Anton M, Dumler K, Seidl S, Pelisek J, et al. (2009) Combined reporter gene pet and iron oxide mri for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med 50: 1088-1094 DOI:10.2967/jnumed.108.060665.
30. Bai JZ, Ding W, Yu MJ, Du J, Liu ZJ, et al. (2004) Radionuclide imaging of mesenchymal stem cells transplanted into spinal cord. Neuroreport 15: 1117-1120 DOI:10.1097/01.wnr.0000126505.97607.1b.
31. Acton PD, Zhou R, (2005) Imaging reporter genes for cell tracking with PET and SPECT. Q J Nucl Med Mol Imaging 49: 349-360.
32. Chen CY, Lin CY, Chen GY, Hu YC, (2011) Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29: 618-631 DOI:10.1016/j.biotechadv.2011.04.004.
33. Kost TA, Condreay JP, Jarvis DL, (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23: 567-575 DOI:10.1038/nbt1095.
34. Lin SY, Chen GY, Hu YC, (2011) Recent patents on the baculovirus systems. Recent Pat Biotechnol 5: 1-11 DOI:http://dx.doi.org/10.2174/187220811795655904.
35. Kim YH, Lee DS, Kang JH, Lee YJ, Chung JK, et al. (2005) Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med 46: 305-311.
36. Hwang DW, Jang SJ, Kim YH, Kim HJ, Shim IK, et al. (2008) Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds. Eur J Nucl Med Mol Imaging 35: 1887-1898 DOI:10.1007/s00259-008-0751-z.
37. Chung JK, (2002) Sodium iodide symporter: Its role in nuclear medicine. J Nucl Med 43: 1188-1200.
38. Zhou X, Li B, Wang J, Yin H, Zhang Y, (2010) The feasibility of using a baculovirus vector to deliver the sodium-iodide symporter gene as a reporter. Nucl Med Biol 37: 299-308 DOI:10.1016/j.nucmedbio.2009.12.007.
39. Liao J, Wu Z, Wang Y, Cheng L, Cui C, et al. (2008) Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res 18: 600-603 DOI:10.1038/cr.2008.51.
40. Wu Z, Li H, Rao LJ, He LXZ, Bao L, et al. (2011) Derivation and characterization of human embryonic stem cell lines from the Chinese population. J Genet Genomics 38: 13-20 DOI:10.1016/j.jgg.2011.12.006.
41. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, et al. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227: 271-278 DOI:10.1006/dbio.2000.9912.
42. Ho YC, Chung YC, Hwang SM, Wang KC, Hu YC, (2005) Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J Gene Med 7: 860-868 DOI:10.1002/jgm.729.
43. Weiss SJ, Philp NJ, Grollman EF, (1984) Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114: 1090-1098 DOI:10.1210/endo-114-4-1090.
44. Zeng J, Du J, Zhao Y, Palanisamy N, Wang S, (2007) Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1055-1061 DOI:10.1634/stemcells.2006-0616.
45. Du J, Zeng JM, Zhao Y, Boulaire J, Wang S, (2010) The combined use of viral transcriptional and post-transcriptional regulatory elements to improve baculovirus-mediated transient gene expression in human embryonic stem cells. J Biosci Bioeng 109: 1-8 DOI:10.1016/j.jbiosc.2009.06.017.
46. Shen HC, Lee HP, Lo WH, Yang DG, Hu YC, (2007) Baculovirus-mediated gene transfer is attenuated by sodium bicarbonate. J Gene Med 9: 470-478 DOI:10.1002/jgm.1037.
47. Mahonen AJ, Makkonen KE, Laakkonen JP, Ihalainen TO, Kukkonen SP, et al. (2010) Culture medium induced vimentin reorganization associates with enhanced baculovirus-mediated gene delivery. J Biotechnol 145: 111-119 DOI:10.1016/j.jbiotec.2009.11.003.
48. Hsu CS, Ho YC, Wang KC, Hu YC, (2004) Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 88: 42-51 DOI:10.1002/bit.20213.
49. Chen CY, Wu HH, Chen CP, Chern SR, Hwang SM, et al. (2011) Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharm 8: 1505-1514 DOI:10.1021/mp100368d.
50. Ho YC, Lee HP, Hwang SM, Lo WH, Chen HC, et al. (2006) Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther 13: 1471-1479 DOI:10.1038/sj.gt.3302796.
51. Lo WH, Hwang SM, Chuang CK, Chen CY, Hu YC, (2009) Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther 17: 658-666 DOI:10.1038/mt.2009.13.
52. Lin CY, Lin KJ, Kao CY, Chen MC, Lo WH, et al. (2011) The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials 32: 6505-6514 DOI:10.1016/j.biomaterials.2011.05.059.
53. Hu YC, (2008) Baculoviral vectors for gene delivery: A review. Curr Gene Ther 8: 54-65 DOI:10.2174/156652308783688509.
54. Zhang XJ, Godbey WT, (2006) Viral vectors for gene delivery in tissue engineering. Adv Drug Deliv Rev 58: 515-534 DOI:10.1016/j.addr.2006.03.006.
55. Hartley JL, (2006) Cloning technologies for protein expression and purification. Curr Opin Biotechnol 17: 359-366 DOI:10.1016/j.copbio.2006.06.011.
56. Hu YC, (2006) Baculovirus vectors for gene therapy. Adv Virus Res 68: 287-320 DOI:10.1016/s0065-3527(06)68008-1.
57. Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, et al. (2009) The Na+/I- symporter mediates active iodide uptake in the intestine. Am J Physiol-Cell Physiol 296: C654-C662 DOI:10.1152/ajpcell.00509.2008.
58. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE, (1998) Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 83: 1746-1751 DOI:10.1210/jc.83.5.1746.
59. Vayre L, Sabourin JC, Caillou B, Ducreux M, Schlumberger M, et al. (1999) Immunohistochemical analysis of Na+/I- symporter distribution in human extra-thyroidal tissues. Eur J Endocrinol 141: 382-386 DOI:10.1530/eje.0.1410382.